Boothbay Fund Management »

Sonnet Biotherapeutc Hldng I shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $258k 56k 4.58

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Sonnet Biotherapeutc Hldng I

Ikarian Capital
Vanguard Group
Hrt Financial
Geode Capital Management
Boothbay Fund Management
Goldman Sachs Group
Citadel Advisors
Virtu Financial
State Street Corporation
BlackRock
Northern Trust
Two Sigma Investments
Investment House
Jane Street
Jpmorgan Chase & Co

View all funds holding Sonnet Biotherapeutc Hldng I